Clinical Trial Update: Positron Emission Tomography and CT Scan in Predicting Response in Patients With Metastatic Melanoma or Kidney Cancer Who Are Undergoing Cellular Adoptive Immunotherapy on a Surgery Branch Clinical Trial [Phase 2]

View source ↗

Summary

Phase 2 study evaluating whether positron emission tomography (PET) and CT imaging can predict response in patients with metastatic melanoma or kidney cancer re…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Kidney Cancer
• Melanoma

Drugs mentioned

• Cellular adoptive immunotherapy (adoptive cell transfer) (adoptive cell transfer)

Snippet

Sponsor: National Institutes of Health Clinical Center (CC) | Conditions: Kidney Cancer, Melanoma (Skin) | Phase 2 | Status: COMPLETED